Skip to main content
SpringerLink
Log in

Ghrelin and cortistatin in lung cancer: Expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Ghrelin, a natural GH secretagog (GHS) acylated peptide, and cortistatin (CST), a natural SRIF-like peptide, interfere with neoplastic growth in different cancers. We tested forty-one lung carcinomas and the H345 small cell lung carcinoma (SCLC) cell line by RT-PCR to investigate the presence of ghrelin and CST and related receptors, including type 1a GHS receptor (GHS-R1a), all SRIF-receptor subtypes (sst 1–5) and MRGX2. Moreover, the presence of ghrelin and CST peptides was studied in both tumors and H345 cells. Ghrelin and CST mRNA were present in the majority of tested tumors, but ghrelin and CST proteins were revealed only in tumors with a neuroendocrine phenotype. All the receptors mRNA had a heterogeneous expression without correlation between ghrelin (or CST) and their receptor distribution. All the transcripts, but not GHS-R1a, were expressed in H345 cells. However, ghrelin and desacyl ghrelin induced in vitro a dose-dependent inhibition on the H345 cell proliferation and increased apoptosis. Conversely, neither CST nor SRIF affected H345 cell growth, despite the presence of their specific receptors. The anti-proliferative and the pro-apoptotic effects of ghrelin were consistent with binding experiments on H345 cell, where either acylated or des-acylated ghrelin recognized a common binding site. In conclusion, the present study indicates that: a) ghrelin and CST mRNAs are expressed in lung cancers, although some neuroendocrine tumors contain detectable amounts of the peptides; b) GHSR-1a mRNA is present exclusively in neuroen-docrine tumors, whereas MRGX2 mRNA (but not peptide) is expressed in all histological types; c) both ghrelin forms inhibit H345 cell proliferation, both directly and enhancing apoptosis, despite the absence of GHS-R1a, whereas CST and its receptors do not interfere with cell growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone acylated peptide from stomach. Nature 1999, 402: 656–66.

    Article  PubMed  CAS  Google Scholar 

  2. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12: 118–22.

    Article  PubMed  CAS  Google Scholar 

  3. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25: 426–57.

    Article  PubMed  CAS  Google Scholar 

  4. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin-ahormone with multiple functions. Front Neuroen-docrinol 2004, 25: 27–68.

    Article  CAS  Google Scholar 

  5. Arvat E, Maccario M, di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnaturalpeptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86: 1169–74.

    PubMed  CAS  Google Scholar 

  6. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141: 4325–8.

    Article  PubMed  CAS  Google Scholar 

  7. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002, 440: 235–54.

    Article  PubMed  CAS  Google Scholar 

  8. Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 2000, 275: 21995–2000.

    Article  PubMed  CAS  Google Scholar 

  9. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000, 279: 909–13.

    Article  PubMed  CAS  Google Scholar 

  10. Torsello A, Ghe’ C, Bresciani E, et al. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology 2002, 143: 1968–71.

    Article  PubMed  CAS  Google Scholar 

  11. Broglio F, Benso A, Gottero C, et al. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest 2003, 26: 192–6.

    PubMed  CAS  Google Scholar 

  12. Gualillo O, Caminos J, Blanco M, et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001, 142: 788–94.

    PubMed  CAS  Google Scholar 

  13. Volante M, Allia E, Gugliotta P, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002, 87: 1300–8.

    Article  PubMed  CAS  Google Scholar 

  14. Korbonits M, Bustin SA, Kojima M, et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001, 86: 881–7.

    PubMed  CAS  Google Scholar 

  15. Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin Endocrinol (Oxf) 2001, 54: 759–68.

    Article  CAS  Google Scholar 

  16. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 2001, 86: 5052–9.

    Article  PubMed  CAS  Google Scholar 

  17. Yeh AH, Jeffery PL, Duncan RP, Heritngton AC, Chopin LK. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogenactivated protein kinase in prostate cancer. Clin Cancer Res 2005, 11: 8295–303.

    Article  PubMed  CAS  Google Scholar 

  18. Volante M, Allia E, Fulcheri E, et al. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 2003, 162: 645–54.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Howard AD, Feighner SC, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273: 974–7.

    Article  PubMed  CAS  Google Scholar 

  20. McKee KK, Palyha OC, Feighner SD, et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 1997, 11: 415–23.

    Article  PubMed  CAS  Google Scholar 

  21. Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palu G. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 2005, 68: 414–21.

    Article  PubMed  CAS  Google Scholar 

  22. Cassoni P, Papotti M, Ghe C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001, 86: 1738–45.

    PubMed  CAS  Google Scholar 

  23. Cassoni P, Ghe C, Marrocco T, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004, 150: 173–84.

    Article  PubMed  CAS  Google Scholar 

  24. Belloni AS, Macchi C, Rebuffat P, et al. Effect of ghrelin on the apoptotic deletion rate of different types of cells cultured in vitro. Int J Mol Med 2004, 14: 165–7.

    PubMed  CAS  Google Scholar 

  25. Ghe C, Cassoni P, Catapano F, et al. The antiproliferative effect of synthetic peptidyl GH secretagoguesin human CALU-1 lung carcinoma cells. Endocrinology 2002, 143: 484–91.

    Article  PubMed  CAS  Google Scholar 

  26. Spier AD, de Lecea L. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 2000, 33: 228–41.

    Article  PubMed  CAS  Google Scholar 

  27. Broglio F, Arvat E, Benso A, et al. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 2002, 87: 3783–90.

    Article  PubMed  CAS  Google Scholar 

  28. Allia E, Tarabra E, Volante M, et al. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours. J Pathol 2005, 207: 336–45.

    Article  PubMed  CAS  Google Scholar 

  29. Cassoni P, Muccioli G, Marrocco T, et al. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin. J Endocrinol Invest 2002, 25: 362–8.

    Article  PubMed  CAS  Google Scholar 

  30. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and Genetics. Tumors of lung pleura, thymus and heart. In WHO classification of tumors. Lyon: IARC Press (ed). 2004.

    Google Scholar 

  31. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002, 50: 1013–21.

    Article  PubMed  CAS  Google Scholar 

  32. Muccioli G, Papotti M, Locatelli V, Ghigo E, Deghenghi R. Binding of 1251-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 2001, 24: RC7–9.

    Article  PubMed  CAS  Google Scholar 

  33. Gerling N, Culmsee C, Klumpp S, Krieglstein J. The tyrosine phosphatase inhibitor orthovanadate mimics NGF-induced neuroprotective signaling in rat hippocampal neurons. Neurochem Int 2004, 44: 505–20.

    Article  PubMed  CAS  Google Scholar 

  34. Bednarek MA, Feighner SD, Pong SS, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 2000, 43: 4370–6.

    Article  PubMed  CAS  Google Scholar 

  35. Kanamoto N, Akamizu T, Hosoda H, et al. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab 2001, 86: 4984–90.

    Article  PubMed  CAS  Google Scholar 

  36. Jeffery PL, Herington AC, Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002, 172: R7–11.

    Article  PubMed  CAS  Google Scholar 

  37. Gaytan F, Barreiro ML, Caminos JE, et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 2004, 89: 400–9.

    Article  PubMed  CAS  Google Scholar 

  38. Arnaldi G, Mancini T, Kola B, et al. Cyclical Cushing’s syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 2003, 88: 5834–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences and Human Oncology, University of Torino, Via Santena 7, 10126, Torino, Italy

    P. Cassoni MD, E. Allia & T. Marrocco

  2. Anatomy, Pharmacology and Forensic Medicine, University of Turin, Turin, Italy

    C. Ghè & G. Muccioli

  3. Internal Medicine, University of Turin, Turin, Italy

    E. Ghigo

  4. Clinical and Biological Sciences, University of Turin, Turin, Italy

    M. Papotti

Authors
  1. P. Cassoni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Allia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Marrocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Ghè
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Muccioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Papotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Cassoni MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassoni, P., Allia, E., Marrocco, T. et al. Ghrelin and cortistatin in lung cancer: Expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. J Endocrinol Invest 29, 781–790 (2006). https://doi.org/10.1007/BF03347371

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347371

Key-words

Search

Navigation